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Abstract 
Research reveals a biased preference for natural versus synthetic drugs; however, this research is 
based upon self-report and has not examined ways to reduce the bias. We examined these issues 
in five studies involving 1,125 participants. In a Pilot Study (N = 110), participants rated the term 
natural to be more positive than the term synthetic, which reveals a default natural-is-better 
belief. In Studies 1 (N = 109) and 2 (N = 100), after a supposed personality study, participants 
were offered a thank you “gift” of a natural or synthetic pain reliever. Approximately 86% 
(Study 1) and 93% (Study 2) of participants chose the natural versus synthetic pain reliever, 
which provide a behavioral choice confirmation of the natural drug bias. In Studies 3 (N = 350) 
and 4 (N = 356), participants were randomly assigned to a control or experimental condition and 
were asked to consider a scenario in which they had a medical issue requiring a natural versus 
synthetic drug. The experimental condition included a stronger (Study 3) or weaker (Study 4) 
rational appeal about the natural drug bias and a statement suggesting that natural and synthetic 
drugs can be good or bad depending upon the context. In both studies, the natural bias was 
reduced in the experimental condition, and perceived safety and effectiveness mediated this 
effect. Overall, these data indicate a bias for natural over synthetic drugs in preferences and 
behavioral choices, which might be reduced with a rational appeal. 
 
Key Words: natural bias; natural; preference; synthetic; perception; drug choice; health behavior  
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A Behavioral Confirmation and Reduction of the Natural versus Synthetic Drug Bias  
The terms “natural” or “nature” are often used in product names and marketing materials. 
For example, one can purchase Applegate’s Natural Beef Hot Dogs or Truvia’s Natural 
Sweeteners. Manufacturers may use terms related to natural because people seem to assume that 
natural products are better and safer than unnatural, synthetic, or artificial products. Researchers 
have shown that people generally consider something to be natural when it lacks additives and 
processing
1,2
. Rozin et al.
3
 showed that people preferred foods described as natural rather than 
processed or human made. Research has also found a natural bias with such diverse items as 
cigarettes
4
, cultured or grown meat
5
, perfumes
6
, soda
7
, and even hormone replacement therapy 
among obstetricians and gynecologists
8
.  
Rozin et al.
3 
and others
9
 find that a preference for natural items is based upon 
instrumental and ideational factors. Instrumental factors focus on the attributes of an item (e.g., a 
natural product is safer), whereas ideational factors focus on the inherent appeal of natural items, 
such as the idea that they are morally better because they are linked to nature. For example, 
participants rated natural versions of items such as cigarettes
4 
or drugs
9 
as safer than the non-
natural or synthetic versions. These ratings suggest that natural may be preferred in some cases 
for instrumental reasons. Yet, the diversity of contexts in which natural is preferred suggests that 
there is also a natural-is-better default belief that operates in some situations. This view may 
coincide with the affect heuristic, or the notion that people’s decisions may be guided by their 
emotions in an intuitive or automatic sense
10 
. For example, if people have positive feelings 
associated with the term natural, this may guide them to process information about a natural 
product in a biased way, or to choose natural even though it may not be the best choice.  We 
examine people’s feelings associated with the term natural in a Pilot Study.            
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Meier and Lappas
11
 examined preferences for natural versus synthetic drugs in a medical 
context. In a series of studies, they found that participants preferred a natural to a synthetic drug 
for a hypothetical medical condition even though the drugs were described as equally effective 
and safe. They found this preference for both minor and serious health conditions. Furthermore, 
some participants even preferred a natural drug when it was described as less safe or less 
effective than a synthetic drug. Additionally, natural drugs were perceived as safer but less 
effective than synthetic drugs regardless of the safety and effectiveness information given.  
The U.S. Food and Drug Administration
12
 does not regulate the term natural and it is 
therefore used to mean different things
13
 such as organic, non-artificial, and derived from plants. 
Yet, research has shown that it is a term that has positive attributes across European and North 
American cultures
2
. Although natural products like drugs can be beneficial, it is inaccurate to 
assume that anything labeled natural is better or safer. For example, botulinum toxin and arsenic 
are natural, but highly deadly. The findings of Meier and Lappas
11
 are concerning given that 
natural drugs, when marketed as supplements, are not always tested for safety and efficacy and 
natural drugs have sometimes been shown to have significant toxicities
14,15
. Furthermore, a bias 
in favor of natural drugs may have consequences for people’s medical decision making. For 
example, people may choose a natural drug for a medical issue rather than a synthetic drug 
prescribed by their doctor. 
Overview of Studies, Data Statement, and Power Statement  
We conducted five studies to examine three questions, (1) do people prefer natural over 
synthetic in the absence of a context?; (2) does the natural drug bias occur in behavior?; and (3) 
can we reduce the natural drug bias? In a Pilot Study, we sought to determine if people believed 
the term natural is more positive than the term synthetic. In Studies 1 and 2, we sought to 
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determine if the natural versus synthetic drug bias would occur in a behavioral encounter. Prior 
work has been based upon hypothetical scenarios, but we used a behavioral decision to 
determine if the bias is reliable. In Studies 3 and 4, we sought to determine if we could reduce 
the natural drug bias using a rational appeal. All studies were approved either by the Gettysburg 
College or Grand Valley State University Institutional Review Boards. 
In all of our studies, we report all measures, conditions, data exclusions, and the manner 
in which we determined sample sizes. We did not include any covariates in our analyses. All 
study materials and data are available upon request to the first author.  
In five studies examining the natural versus synthetic drug bias, Meier and Lappas 
(2016)
11
 found medium to large effect sizes. In their Studies 1a, 1b, and 4, which found the 
standard natural bias (e.g., would you choose a natural or synthetic drug?), the effect sizes found 
were Cramer’s Phis = .58, .52, and .28 (for interpretation, .50 is large & .30 is medium16). In 
their Studies 2 and 3, they found that manipulations related to safety and efficacy were 
moderated by whether a drug was described as natural or synthetic (e.g., do people choose a 
natural or synthetic drug when the natural drug is less safe or less effective?) and the effect sizes 
for this moderation were medium, Cramer’s Phis = .26 and .33. While these studies are not 
identical to our studies, they are the best effect size estimates available. In order to be 
conservative, we chose the low end and used a medium effect size estimate (Cramer’s Phi = .30) 
for our a priori power analyses since our hypotheses were tested with a Chi Square test in Studies 
1 through 4. In the Pilot Study, we use a dependent-samples t test to examine the hypothesis and 
we use a medium effect size again to estimate sample size, in this case d  (a medium effect size 
with d = .50
16
). These power analyses are presented in the respective sections of the Pilot Study, 
Studies 1 and 2, and Studies 3 and 4.   
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Pilot Study 
 We estimated sample size using a medium effect size (d = .50
16
). A dependent-samples t 
test was used to examine the hypothesis that participants would rate “natural” to be more positive 
than “synthetic”. We used G*Power 3.1 and found that a sample of 34 participants was required 
to reach 80% power. We sought to be conservative and attempted to collect data from 100 
participants.    
Method 
Participants 
Participants were 110 individuals (47 females; 61 males 2 non-report) with a mean age of 
33.86 (SD = 11.15) years. The majority of the participants self-identified as Caucasian (87 or 
79.10%), and the remaining participants self-identified as Asian/Pacific Islander (14 or 12.70%), 
Black (4 or 3.60%), mixed race (2 or 1.80%), Hispanic (1 or .90%), or unknown (1 or .90%). 
One participant did not report race. We removed five participants who gave the same rating for 
all words (leaving 105 participants).  
Participants came from Amazon’s Mechanical Turk (MTurk), a crowdsourcing website 
with thousands of individuals
17,18
. Participants from MTurk have been shown to be more 
demographically diverse than typical college student samples and to produce data as reliable as 
laboratory-based data
11,17
. We recruited people living in the U.S. who were 18 years of age or 
older (using MTurk’s participant selection options). Participants were paid $0.35 for completing 
the study.  
Materials and Procedures 
We told participants on the consent form that the purpose of the research “is to learn 
about people's judgments and perceptions of common things”. Participants were also told “you 
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will be asked to rate a number of words in terms of how negative or positive they are in 
meaning.” Before the ratings started, participants were told to “please rate the words below in 
terms of their negative or positive meaning”. Participants rated the valence (1 = very negative to 
5 = neutral to 9 = very positive) of 17 words including natural and synthetic as well as filler 
words unrelated to these domains in order to disguise our true interest (kiss, region, horror, 
fireworks, hut, mistake, chart, dirty, fat, beach, cake, barrel, reward, garbage, & pour). Natural 
and synthetic occurred in the 7
th
 and 14
th
 positions, counter-balanced across participants. 
Participants were debriefed at the end of the study.   
Results and Discussion 
Participants rated natural (M = 6.78; SD = 1.28) as much more positive than synthetic (M 
= 4.50; SD = 1.27), t(104) = 12.01, p < .001, d = 1.17. Additionally, the natural rating was 
significantly above the neutral point of 5, t(104) = 14.29, p < .001, d = 1.39, while the synthetic 
rating was significantly below the neutral point of 5, t(104) = -3.99, p < .001, d = -.39. The 
remaining filler words were rated in a manner consistent with their expected meaning (e.g., 
garbage was rated as being more negative than kiss). These rating results for natural and 
synthetic are consistent with a large normed word set that includes these terms
19
.   
These results suggest that there is an inherent positive belief about natural in a context-
free situation. Additionally, the results show that the natural rating was three times farther from 
the mid-point of the scale than the synthetic rating. Thus, one reason for a natural bias may be 
due to a default natural-is-better default belief. In other words, people may prefer natural to 
synthetic, whether the item is food, drugs, beauty products or anything else. In the remaining 
studies, we specifically examine a behavioral confirmation (Studies 1 and 2) and attempted 
reduction (Studies 3 and 4) of the natural drug bias.  
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Study 1 
 In Studies 1 and 2, we estimated sample sizes using a medium effect size (Cramer’s Phi = 
.30). A Chi-Square test goodness of fit was used to examine the hypothesis that participants 
would be more likely to choose the natural versus synthetic pain reliever. We used G*Power 3.1 
and found that a sample of 88 participants was required to reach 80% power. We again sought to 
be conservative and attempted to collect data from at least 100 participants in each study.  
Method 
Participants 
Participants were 109 individuals (75 females; 34 males) with a mean age of 22.10 (SD = 
9.09) years. They were recruited from the campus of Gettysburg College in Pennsylvania, U.S. 
The majority of the participants self-identified as Caucasian (90 or 82.60%), and the remaining 
participants self-identified as Hispanic (10 or 9.20%), Asian/Pacific Islander (5 or 4.60%), or 
Black (2 or 1.80%). Two (1.80%) participants selected an “other” category.  
Materials and Procedure 
Due to the inherent challenges of conducting an ethical study examining the actual 
consumption of a natural versus synthetic drug, we focused on a behavioral choice that appeared 
real. We contacted participants walking on campus under the guise of a personality study, but we 
were really interested in whether people would accept a natural or synthetic pain reliever for 
participating in a study. A research assistant was instructed to walk around campus and look for 
potential participants who did not appear busy and were walking alone. Once a potential 
participant was identified, the research assistant approached and said:  
“I’m running a psychology study and was wondering if you had 5 minutes to complete a 
simple questionnaire. I’ll give you a chocolate bar for participating.”  
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If participants agreed to take part in the study, the research assistant gave the participant a 
consent form to read and complete. Upon completion of the consent form, the research assistant 
gave the participant a personality questionnaire with 20 items. This questionnaire was used to 
reduce suspicions about the true purpose of the study, which was to determine if people would 
select a natural or synthetic pain reliever. The research assistant gave participants privacy during 
completion of this questionnaire by stepping back a few feet. When participants completed the 
personality items, they turned the page over and completed demographic questions. Upon 
completion of the questionnaire, the research assistant said: 
“Thanks for completing the questionnaire. Here is the candy bar (research assistant 
reached in a bag). Ahh, actually I forgot to tell you that our department has received 
several free samples of new non-prescription pain relievers. We decided to give them 
away to participants. We have two types, and we can give you one today for 
participating. One is a synthetic drug created in the laboratory by scientists and the other 
is a natural drug taken from a common plant. Which one would you like?”  
We used the descriptions of natural and synthetic drugs created by Meier and Lappas
11
. We did 
not have actual pain relievers, but we wanted to make participants believe they would be 
receiving an actual drug. Although we have no way of knowing if participants viewed our cover 
story as credible, it did place them in a real situation in which a choice was necessary. After 
participants made a drug choice (no drug, natural, or synthetic), the research assistant debriefed 
the participants by telling them the true nature of the study. Finally, the research assistant gave 
participants a Hershey’s chocolate bar and recorded participants’ drug choices.  
Results and Discussion 
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 An unbiased finding would be one in which participants chose the drugs at an equal rate 
(50% for each drug) given that no additional information was provided. Figure 1 (left side) 
illustrates the frequency of the three choices, no drug, natural drug, and synthetic drug. Sixty of 
the 109 participants indicated that they did not want either of the drugs. We examined the data of 
the remaining 49 participants. Forty-two participants or 85.71% of these 49 participants chose 
the natural drug whereas 7 or 14.29% of these 49 participants chose the synthetic drug. This 
difference was statistically different from a 50%-50% split and illustrates a strong natural drug 
bias for a behavioral choice, 2 (1, N = 49) = 25.00, p < .001, Cramer’s Phi = .71.  
In Study 2, we sought to replicate Study 1 with a different sample of participants from 
another location in the U.S. Additionally, we wanted to address two potential issues. First, a 
large number of participants did not choose a pain reliever in Study 1 and therefore it could be 
that these participants differ in some way from participants who did choose a pain reliever, 
making our effect larger than it may be in realty. Therefore, in Study 2, participants who did not 
want a pain reliever were asked to tell us which one they would choose if they had to take one. 
Although this question is hypothetical, it allows us to determine if these individuals differ from 
those who chose a pain reliever. Second, the definitions of natural and synthetic used in Study 1 
(a synthetic drug created in the laboratory by scientists; a natural drug taken from a common 
plant) differed on multiple dimensions. For example, the terms “laboratory”, “scientists”, and 
“common plant” were only used in one condition or the other. These differences could have led 
participants to make a choice that had more to do with the terms rather than preferences related 
to natural or synthetic. In Study 2, we used definitions for natural and synthetic that only varied 
on one dimension: a synthetic drug created from ingredients NOT FOUND in nature versus a 
natural drug created from ingredients FOUND in nature. Both definitions are identical except for 
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the word “not”. This definition also coincides with what people believe natural means such as 
lacking additives and processing
1,2
. 
Study 2 
Method 
Participants 
Participants were 100 individuals (71 females; 28 males; 1 reported neither male or 
female) with a mean age of 20.35 (SD = 2.51) years. They were recruited from the campus of 
Grand Valley State University in Michigan, U.S. The majority of the participants self-identified 
as Caucasian (84 or 84%), and the remaining participants self-identified as Hispanic (6 or 6%), 
Black (6 or 6%), Asian/Pacific Islander (2 or 2%), and American India/Alaskan Native (2 or 
2%).  
Materials and Procedure 
We followed the same procedures from Study 1 and also used the same instructions and 
materials with two exceptions. One, if participants said they did not want a pain reliever, we 
asked them to tell us which one they would want (natural or synthetic) if they had to choose. 
Two, we used new definitions of natural and synthetic in our description of the pain relievers:  
“Thanks for completing the questionnaire. Here is the candy bar (research assistant 
reached in a bag). Ahh, actually I forgot to tell you that our department has received 
several free samples of new non-prescription pain relievers. We decided to give them 
away to participants. We have two types, and we can give you one today for 
participating. One is a synthetic drug made from ingredients not found in nature and one 
is a natural drug made from ingredients found in nature. Which one would you like?”  
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After participants made a drug choice, the research assistant debriefed the participants by telling 
them the true nature of the study. Finally, the research assistant gave participants a Hershey’s 
chocolate bar and recorded participants’ drug choices.  
Results and Discussion 
 Figure 1 (right side) illustrates the frequency of the three choices, no drug, natural drug, 
and synthetic drug. Eleven of the 100 participants indicated that they did not want either of the 
drugs and were asked the follow-up question. We found that 10 or 90.91% of these 11 
participants chose the natural drug, 2 (1, N = 11) = 7.36, p = .01, Cramer’s Phi = .82.  
The remaining 89 participants chose a pain reliever. Eighty-three or 93.26% of these 89 
participants chose the natural drug whereas 6 or 6.74% of these 89 participants chose the 
synthetic drug. This difference was statistically different from a 50%-50% split and again 
illustrates a strong natural drug bias for a consequential behavioral choice, 2 (1, N = 89) = 
66.62, p < .001, Cramer’s Phi = .87.  
This study replicates the findings from Study 1 with the new definitions and with 
participants from a different location. We also showed that participants who did not choose a 
drug still showed a strong natural drug bias when asked to make a choice. It appears that fewer 
participants refused a drug in Study 2 (11%) compared to Study 1 (55.05%). It is impossible to 
determine the exact reason for this apparent difference as there are a number of potential 
possibilities: the change in participant location (liberal arts college in the Northeast U.S. versus 
public university in the Midwest U.S.), the use of different research assistants, the change in 
definitions, or some other unknown variable. We address this issue further in the General 
Discussion section. In Studies 3 and 4, we used a hypothetical scenario-based design and sought 
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to determine if we could reduce the natural drug bias with the inclusion of a randomly assigned 
rational appeal. 
Study 3 
 In Studies 3 and 4, we estimated sample sizes using a medium effect size (Cramer’s Phi = 
.30). A 2 x 2 Chi-Square test for independence was used to examine the hypothesis that 
participants would be less likely to choose a natural versus synthetic drug when given a rational 
appeal. G*Power 3.1 does not offer a sample size estimate option for a Chi-Square test for 
independence when examining an exact effect size. We therefore used estimates from a power 
table for a Chi-Square test for independence
16
. This information revealed that 87 total 
participants were needed to reach 80% power. Yet, because we knew that an attempt to reduce 
the natural bias has not been conducted in the past, and a true effect size was unknown, we 
sought to collect data from as many participants as possible given our financial resources. We 
therefore attempted to collect data from at least 350 participants in Studies 3 and 4.   
Method 
Participants 
Participants in Study 3 came from MTurk. We recruited people living in the U.S. who 
were 18 years of age or older. Participants were paid $0.75 for their participation. Participants 
were 350 individuals (178 males; 171 females; 1 queer) with a mean age of 34.63 (SD = 10.37) 
years. The majority of the participants self-identified as Caucasian (275 or 78.60%), and the 
remaining participants self-identified as Hispanic (25 or 7.10%), Asian/Pacific Islander (25 or 
7.10%), Black (23 or 6.60%), American Indian/Alaskan Native (1 or .30%), or mixed (1 or 
.30%). We removed 13 participants who stated that they completed a study before with questions 
similar to the ones used in Studies 1 and 2. Therefore, we analyzed data from 337 participants.    
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Materials and Procedure 
 Participants first gave informed consent and were then told that researchers were 
interested in their judgments and perceptions about common things like drugs. Participants were 
randomly assigned to one of two conditions using the scenarios previously published by Meier 
and Lappas
11
. We used the definitions of natural and synthetic used in Study 1. In both 
conditions, participants were told to:  
“Imagine that you learn that you have a medical condition and you need to take a drug to 
treat it. You have to choose between one of the two options shown below: 
 Option 1 is a synthetic drug created in the laboratory by scientists. 
 
 Option 2 is a natural drug taken from a common plant.” 
Participants in the control condition received the above question without any additional details 
and were simply asked to choose one of the two options. Participants in the experimental 
condition also received the following rational appeal:  
“Some people think natural substances are better than synthetic substances. However, 
many scientists would agree that it is inaccurate to make this assumption. For example, 
natural substances such as Botulinum Toxin and Arsenic are poisons that can cause death 
when people are exposed to small amounts. Furthermore, synthetic substances are not 
inherently bad. Tylenol and many Anti-Cancer Drugs are synthetic substances and are 
beneficial for humanity. Overall, sometimes natural substances are good or bad and 
sometimes synthetic substances are good or bad.” 
We developed this appeal in collaboration with a Ph.D. synthetic and organic chemist to 
ensure it was scientifically sound. The appeal was purposely written so that participants would 
know that it is inaccurate to automatically choose a natural drug. After providing their choice and 
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consistent with the work by Meier and Lappas
11
, participants were asked to rate their perceptions 
of the safety and effectiveness of each drug using a 1 (not at all) to 9 (very) scale. Participants 
also completed the Short Item Need for Cognition scale
20
, which was included for exploratory 
purposes and was not part of the current project. Finally, participants completed demographic 
questions and were debriefed.
 
 
Results and Discussion 
An unbiased finding would be one in which participants chose the drugs at an equal rate 
(50% for each drug) and perceived the drugs as similarly safe and effective. Yet, as found in 
Meier and Lappas
11
, we predicted that in the control condition, participants would choose the 
natural drug more frequently than the synthetic drug and would rate it as safer, but less effective. 
However, we expected these effects to be reduced in the experimental condition. These 
hypotheses were confirmed. As shown in Figure 2, participants selected the natural drug 
significantly more frequently in the control condition (122 of 173 or 70.50% of participants) 
compared to the experimental condition (71 of 164 or 43.30% of participants), χ2 (1, N = 337) = 
25.51, p < .001, Cramer’s Phi = .28. Thus, the rational appeal reduced the natural drug bias. We 
also examined drug choice within each condition separately. The drug choice was different from 
a 50-50% split in the control condition, χ2 (1, N = 173) = 29.14, p < .001, Cramer’s Phi = .41, but 
not in the experimental condition, χ2 (1, N = 164) = 2.95, p = .09, Cramer’s Phi = .13).  
We next examined perceived safety for each drug as a function of condition (Note: one 
participant did not complete the safety ratings). We conducted a mixed-model ANOVA with 
condition (control versus experimental) as a between-participants variable and safety rating of 
drug type (natural versus synthetic) as a within-participants variable. We found a main effect of 
drug type such that overall, participants rated the natural drug as safer (M = 6.45; SD = 1.58) 
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than the synthetic drug (M = 5.53; SD = 1.96), F(1, 334) = 44.79, p = < .001, η2p = .12. However, 
this main effect was qualified by a significant interaction between condition and drug type, F(1, 
334) = 19.78, p = < .001, η2p = .06. We conducted two paired-samples t tests to examine the 
safety ratings of the natural versus synthetic drug for each condition. Participants in the control 
condition rated the natural drug as safer (M = 6.82; SD = 1.49) than the synthetic drug (M = 5.32; 
SD = 2.08), t(1, 172) = 7.68, p < .001, d = .58, but the difference in ratings in the experimental 
condition between the natural (M = 6.06; SD = 1.58) and synthetic (M = 5.75; SD = 1.81) drugs 
was not significant, t(1, 162) = 1.64, p = .10, d = .13. The main effect of condition was not 
significant, F(1, 334) = 1.43, p = .23, η2p < .01. These results suggest that the experimental 
manipulation reduced the safety-rating bias for natural drugs.  
We next examined perceived effectiveness for each drug as a function of condition (Note: 
two participants did not complete the effectiveness ratings). We conducted a mixed-model 
ANOVA with condition (control versus experimental) as a between-participants variable and 
effectiveness rating of drug type (natural versus synthetic) as a within-participants variable. We 
found a main effect of drug type such that overall, participants rated the synthetic drug as more 
effective (M = 6.67; SD = 1.67) than the natural drug (M = 5.99; SD = 1.58), F(1, 333) = 30.57, p 
= < .001, η2p = .08. This main effect was qualified by a significant interaction between condition 
and drug type, F(1, 333) = 4.87, p = .03, η2p = .01. We ran two paired-samples t tests to examine 
the effectiveness ratings of the natural versus synthetic drug for each condition. Participants in 
the control condition rated the synthetic drug as more effective (M = 6.54; SD = 1.77) than the 
natural drug (M = 6.13; SD = 1.66), t(1, 172) = 2.14, p =.03, d = .16. Participants in the 
experimental condition also rated the synthetic drug as more effective (M = 6.81; SD = 1.53) 
than the natural drug (M = 5.85; SD = 1.47), t(1, 161) = 6.25, p < .001, d = .49, although the 
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effect size was three times as large. The main effect of condition was not significant, F < 1. 
These results suggest that the experimental manipulation increased the effectiveness rating of the 
synthetic drug relative to the natural drug.  
Finally, we examined safety and effectiveness ratings as potential mediators of the effect 
between the manipulation and drug choice. In other words, might safety and effectiveness beliefs 
be two potential reasons why the rational appeal reduced the choice of a natural drug? To 
examine this question, we computed two difference scores by subtracting the synthetic drug 
rating from the natural drug rating for both safety and effectiveness. Positive scores mean that 
participants rated the natural drug as safer/more effective than the synthetic drug, and negative 
scores mean that participants rated the synthetic drug as safer/more effective than the natural 
drug. We used Mplus (version 8) to examine mediation and included both the safety and 
effectiveness ratings difference scores in the model. The manipulation was coded as -1 (control 
condition) and 1 (experimental condition) and drug choice was coded as 1 (synthetic drug) and 2 
(natural drug). The results revealed that both difference scores were significantly related to the 
manipulation (safety: β = -.24, p < .001; effectiveness: β = -.12, p = .03) and drug choice (safety: 
β = .63, p < .001; effectiveness: β = .59, p < .001). In terms of mediation, the indirect effects of 
safety (β = -.15, p < .001, 95% CI = -.21 to -.09) and effectiveness (β = -.07, p = .03, 95% CI = -
.13 to -.01) were both significant and different from zero. These indirect effects suggest that the 
link between the manipulation and drug choice was partially driven by perceived safety and 
effectiveness.  
 The results of Study 3 suggest that a rational appeal may reduce the natural drug bias and 
two potential mechanisms appeared to be perceived safety and effectiveness. Yet, Study 3 had 
some potential issues that we sought to address in Study 4. First, we used the new definitions for 
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both the natural and synthetic drugs. Second, we used a different rational appeal that was neutral 
in tone compared to the appeal used in Study 3, which favored the synthetic drug choice. We 
made this second change to determine if the natural drug bias would be reduced with a less 
heavy-handed appeal that made our hypothesis potentially less apparent to participants. 
 Study 4 
Method 
Participants 
Participants in Study 4 came from MTurk. We recruited people living in the U.S. who 
were 18 years of age or older. Participants were paid $0.50 for their participation. Participants 
were 356 individuals (172 males; 182 females; 1 non-binary) with a mean age of 37.18 (SD = 
13.12) years. The majority of the participants self-identified as Caucasian (260 or 73.00%), and 
the remaining participants self-identified as Black (36 or 10.10%), Hispanic (21 or 5.90%), 
American Indian/Alaskan Native (18 or 5.10%), Asian/Pacific Islander (16 or 4.50%), mixed (2 
or .60%), or Arab (1 or .30%). As in Study 3, we removed participants who stated that they 
completed a study before with questions similar to the ones used. Therefore, we removed data 
from 55 participants leaving us with data from 301 participants. 
Materials and Procedure 
 Participants first gave informed consent and were then told that researchers were 
interested in their judgments and perceptions about common things like drugs. Participants were 
randomly assigned to one of two conditions using the same procedures from Study 3 with 
changes to the response options and rational appeal. In both conditions, participants were told to:  
“Imagine that you learn that you have a medical condition and you need to take a drug to 
treat it. You have to choose between one of the two options shown below: 
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 Option 1 is a synthetic drug created from ingredients NOT FOUND in nature.  
 
 Option 2 is a natural drug created from ingredients FOUND in nature.” 
Participants in the control condition received the above question without any additional details 
and were simply asked to choose one of the two options. Participants in the experimental 
condition also received the following appeal:  
 “Some people have a bias when choosing between natural and synthetic drugs. Yet, it is 
known that both natural and synthetic drugs may be either helpful or harmful. For 
example, there are both natural and synthetic poisons that cause death when people are 
exposed to small amounts. Furthermore, there are both natural and synthetic drugs that 
are beneficial for human health. Overall, some natural drugs are good and some are bad, 
and some synthetic drugs are good and some are bad.” 
This rational appeal included a neutral tone between the benefits and costs of synthetic 
and natural drugs. This change allowed us to determine if a neutral appeal would reduce the 
natural drug bias as compared to the stronger appeal used in Study 3. After providing their 
choice, participants also rated their perceived safety and effectiveness of each drug. Finally, 
participants completed demographic questions and were debriefed
. 
 
Results and Discussion 
An unbiased finding would be one in which participants chose the drugs at an equal rate 
(50% for each drug) and perceived the drugs as similarly safe and effective. Yet, as found in 
Study 3, we predicted that in the control condition, participants would choose the natural drug 
more frequently than the synthetic drug and would rate it as safer, but less effective. However, 
we expected these effects to be reduced in the experimental condition. As shown in Figure 3, 
participants selected the natural drug significantly more frequently in the control condition (114 
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of 142 or 80.30% of participants) compared to the experimental condition (113 of 159 or 71.10% 
of participants), but this difference was not quite significant at the traditional level, χ2 (1, N = 
301) = 3.43, p = .06, Cramer’s Phi = .11. The rational appeal appeared to reduce the natural drug 
bias, but not significantly. We also examined drug choice within each condition separately. The 
drug choice was different from a 50-50% split in the control condition, χ2 (1, N = 142) = 52.09, p 
< .001, Cramer’s Phi = .61, and in the experimental condition, χ2 (1, N = 159) = 28.23, p < .001, 
Cramer’s Phi = .42).  
We next examined perceived safety for each drug as a function of condition. We 
conducted a mixed-model ANOVA with condition (control versus experimental) as a between-
participants variable and safety rating of drug type (natural versus synthetic) as a within-
participants variable. We found a main effect of drug type such that overall, participants rated the 
natural drug as safer (M = 6.42; SD = 1.63) than the synthetic drug (M = 4.87; SD = 1.85), F(1, 
299) = 141.54, p < .001, η2p = .32. However, this main effect was qualified by a significant 
interaction between condition and drug type, F(1, 299) = 21.77, p < .001, η2p = .07. We 
conducted two paired-samples t tests to examine the safety ratings of the natural versus synthetic 
drug for each condition. Participants in the control condition rated the natural drug as safer (M = 
6.54; SD = 1.72) than the synthetic drug (M = 4.33; SD = 1.84), t(141) = 10.09, p < .001, d = .86, 
and participants in the experimental condition also rated the natural drug as safer (M = 6.32; SD 
= 1.54) than the synthetic drug (M = 5.36; SD = 1.73), t(158) = 6.06, p < .001, d = .54, although 
the effect size was smaller. The main effect of condition was also significant, F(1, 299) = 7.86, p 
= .01, η2p =.03. This effect revealed that participants in the experimental condition gave higher 
safety ratings overall (M = 5.84; SD = 1.26) than participants in the control condition (M = 5.43; 
SD = 1.25). Overall, these effects suggest that the experimental condition reduced the safety-
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rating bias for natural drugs compared to the control condition as in Study 3, but the difference 
between the safety rating of the natural and synthetic drugs was still significant in the 
experimental condition.  
We next examined perceived effectiveness for each drug as a function of condition. We 
conducted a mixed-model ANOVA with condition (control versus experimental) as a between-
participants variable and effectiveness rating of drug type (natural versus synthetic) as a within-
participants variable. None of the effects were significant at the traditional level, main effect of 
drug type: F(1, 299) = .02, p = .89, η2p < .001, main effect of condition: F(1, 299) = 3.87, p = 
.50, η2p = .01, and the interaction between drug type and condition: F(1, 299) = 3.70, p = .06, η
2
p 
= .01. The means and standard deviations for each condition are shown here: control condition - 
synthetic drug (M = 5.97; SD = 1.90) and natural drug (M = 6.23; SD = 1.66); experimental 
condition - synthetic drug (M = 6.52; SD = 1.66) and natural drug (M = 6.29; SD = 1.65). The 
results for effectiveness ratings do not follow from Study 3 or past work
11
.  
Finally, as in Study 3, we examined safety and effectiveness ratings as potential 
mediators of the effect between the manipulation and drug choice. We again computed two 
difference scores by subtracting the synthetic drug rating from the natural drug rating for both 
safety and effectiveness. We used Mplus (version 8) to examine mediation and included both the 
safety and effectiveness ratings difference scores in the model. The manipulation was coded as -
1 (control condition) and 1 (experimental condition) and drug choice was coded as 1 (synthetic 
drug) and 2 (natural drug). The results revealed that both difference scores were significantly 
related to the manipulation (safety: β = -.26, p < .001; effectiveness: β = -.11, p = .05) and drug 
choice (safety: β = .48, p < .001; effectiveness: β = .55, p < .001). In terms of mediation, the 
indirect effect of safety (β = -.12, p < .001, 95% CI = -.19 to -.05) was significantly different 
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from zero, but the indirect effect of effectiveness (β = -.06, p = .06, 95% CI = -.12 to .01) was 
not significantly different from zero although this effect was close to being significant at the 
traditional level. These indirect effects replicate the pattern from Study 3 and suggest that the 
link between the manipulation and drug choice may be partially driven by safety and 
effectiveness.  
General Discussion 
The results of five studies revealed that participants were biased towards a natural drug in 
both a behavioral decision and in a hypothetical scenario. The results of our studies both 
replicate and extend past work
11
. For example, they conceptually replicate past work in showing 
that participants have a strong bias for natural over synthetic drugs. Our studies extend previous 
work by confirming the bias in a behavioral choice and by showing that the bias can be 
eliminated with a rational appeal. We discuss these results more thoroughly below.  
The Pilot Study revealed that participants rated the term natural as more positive than the 
term synthetic. Such results suggest that natural is an inherently positive concept and may be one 
reason why people seem to prefer natural drugs and other natural items in different contexts. It 
would be informative to determine if the extent to which participants rate natural as positive and 
synthetic as negative partially drives the natural drug bias.   
Studies 1 and 2 appear to be the first studies to find a confirmation of the natural versus 
synthetic drug bias in a behavioral choice context. Past research (and our Studies 3 and 4) has 
been based upon hypothetical scenarios, which is necessary to some extent given the ethical 
limitations with giving people drugs to consume. Therefore, a confirmation of the natural drug 
bias at the behavioral level provides some evidence for the validity of studies involving 
hypothetical scenarios. It is noteworthy that the bias found in Studies 1 and 2 was larger than the 
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bias found in past studies using hypothetical scenarios
11
. These results might suggest that the 
natural drug bias is even stronger when assessed in behavioral paradigms (although see the 
discussion of the limitations of these studies below).  
We attempted to reduce the natural drug bias in Studies 3 and 4 by randomly assigning 
participants to a rational appeal that explained the bias. This appeal reduced the bias in both 
studies, but only significantly in Study 3 (Study 4’s effect was  marginal). Studies 3 and 4 
differed in at least two ways: in Study 4, the new definitions were used as well as the more 
balanced rational appeal. Creative designs that involve different manipulations such as having 
participants read an ostensible science article about the natural drug bias may be able to reduce 
the bias in other ways. Such work is important as we are unaware of any work that has attempted 
to reduce the natural bias in the drug domain or any other domain. Furthermore, such work could 
have implications for medication decisions and adherence to pharmacological regimens, not to 
mention the thoughtless purchases of well-advertised natural supplements. A similar rational 
appeal may be effective in reducing the natural bias found in other areas mentioned earlier such 
as cigarettes, meat, perfume, and soda. 
In Studies 3 and 4, the perception of the safety and effectiveness of natural and synthetic 
drugs was affected by the rational appeal. The appeal reduced the safety rating of the natural 
drug, but also boosted the effectiveness rating of the synthetic drug at least in Study 3. 
Additionally, safety was a significant mediator in both studies and effectiveness was a significant 
mediator in one study and marginally significant in the other. These findings suggest that 
perceptions of safety and effectiveness might be mechanisms involved in both producing and 
reducing the natural drug bias although we recognize that other mechanisms are possible. Of 
note, Meier and Lappas
11
 also found that natural drugs were perceived as safer but less effective 
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than synthetic drugs when all else was equal, and people still showed a natural drug bias. This 
possible disconnect between safety and effectiveness should be examined. It appears that safety 
might be most important to the natural drug bias and thus interventions to reduce the bias need 
only focus on safety. Of course it may also depend on the context in relation to the medical 
decision of interest. Future work will be necessary to fully examine this possibility as well as 
other consequences that may result from a bias in favor of natural drugs.    
Limitations 
 Our studies are not without limitations. First, it is possible that some participants did not 
believe the cover story regarding pain relievers in Studies 1 and 2. Some participants may not 
have believed that the research assistant actually had pain relievers to distribute. We are unable 
to shed light on this possibility as we did not ask follow-up questions in regards to the 
believability of the cover story. While it is not uncommon to receive free products when 
participating in a study, future researchers should use a design that is less susceptible to this 
criticism such as one in which two pain relievers are actually shown to participants (but not 
actually given once a choice is made).  
 Second, it is possible that some of our designs introduced a demand characteristic or a 
desire for participants to behave according to how they thought researchers wanted them to act. 
Research has commonly asked people to choose or rate items described as natural versus 
synthetic, artificial, processed, etc.
1-7
. Therefore, it seems unlikely that a choice task (natural 
versus synthetic) introduced a demand response. Yet, the rational appeal used in Study 3 was 
heavy handed against natural drugs and therefore may have led to a reduction in the bias due to a 
demand explanation rather than due to an actual understanding of the natural versus synthetic 
bias. Study 4 seems less likely to involve such a possibility given that the rational appeal was 
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evenly balanced between natural and synthetic. Future researchers should consider demand-
related  issues when designing manipulations to reduce the natural bias. 
Conclusion  
  In five studies, we found that participants preferred a natural versus a synthetic drug in a 
behavioral context and in hypothetical medical scenarios. The bias was reduced with a rational 
appeal and perceived safety and effectiveness were possible mediators. The overall results 
indicate that the bias for natural drugs is strong, but it may be reduced with a rational appeal.  
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Fig. 1. Frequency of Drug Choice in Studies 1 and 2 
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Fig. 2. Frequency of Drug Choice by Condition in Study 3 
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Fig. 3. Frequency of Drug Choice by Condition in Study 4 
 
 
 
